REVANCE THERAPEUTICS Shareholder Alert: Claimant reminds investors in a class action lawsuit against Revance Therapeutics, Inc. that have lost more than $100,000 to the lead plaintiff deadline-RVNC – QNT Press Release

[ad_1]

New Orleans, December 29, 2021 /PRNewswire/ – ClaimsFiler is a free shareholder information service that reminds investors that they must February 8, 2022 In targeting Revance Therapeutics, Inc. (NASDAQGM:RVNC), if they bought the company’s stock November 25, 2019 and October 11, 2021, Included (“Class Hours”).This operation is pending America North District District Court California.

receive help

Revance investors should visit us https://claimsfiler.com/cases/nasdaq-rvnc-1/ Or call toll free (844) 367-9658. The lawyers of Kahn Swick & Foti,…

The full story on Benzinga.com

[ad_2]

Source link